Literature DB >> 7274588

Increased concentration of albumin in kidney basement membranes in diabetes mellitus.

A F Michael, D M Brown.   

Abstract

The concentration of albumin was measured by a double-antibody radioimmunoassay in the glomerular basement membrane (GBM) and tubular basement membrane (TBM) of patients with diabetic nephropathy, other kidney diseases, and normal kidneys. The TBM from diabetics contained significantly more albumin (m +/ SD; 2.75 +/- 0.34 microgram/mg) than the TBM from other diseases (1.00 +/- 0.24 microgram/mg) or normals (1.21 +/- 0.26 microgram/mg) (P less than 0.0001). Similarly, diabetic GBM contained more albumin (2.25 +/- 0.59 microgram/mg) than other diseases (1.22 +/- 0.55) or normals (1.31 +/- 0.36 microgram/mg) (P less than 0.01-0.001). No differences were observed between the normal and other disease groups. Although there were no differences in hydroxyproline content, there was a highly significant correlation between the concentration of hydroxyproline and albumin in the diabetic TBM (r = 0.82), diabetic GBM (r = 0.70), and normal TBM (r = 0.79). Elution studies with different buffers on frozen sections of diabetic kidneys suggest that the albumin is relatively firmly bound. Although albumin is present in extracellular membranes of normal and diseased human kidneys, the concentration is higher in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7274588     DOI: 10.2337/diab.30.10.843

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Urinary excretion of glycated albumin in insulin-dependent diabetic patients with normal urinary albumin excretion.

Authors:  G Pagano; A Chiambretti; V Calefato; M Tomalino; G Cecchini; A Bruno; P Cavallo-Perin
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

2.  Distribution of endogenous albumin in the glomerular wall of streptozotocin-induced diabetic rats as revealed by high-resolution immunocytochemistry.

Authors:  M Bendayan; D Gingras; P Charest
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

Review 3.  Non-enzymatic glycosylation and the chronic complications of diabetes: an overview.

Authors:  L Kennedy; J W Baynes
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

4.  Preservation of mesangium and immunohistochemically defined antigens in glomerular basement membrane isolated by detergent extraction.

Authors:  M T Houser; J I Scheinman; J Basgen; M W Steffes; A F Michael
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

5.  Selective binding of IgG4 and other negatively charged plasma proteins in normal and diabetic human kidneys.

Authors:  T Melvin; Y Kim; A F Michael
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

6.  Poor metabolic control, hypertension and microangiopathy independently increase the transcapillary escape rate of albumin in diabetes.

Authors:  J A O'Hare; J B Ferriss; B Twomey; D J O'Sullivan
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

7.  Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.

Authors:  R J Falk; A P Dalmasso; Y Kim; C H Tsai; J I Scheinman; H Gewurz; A F Michael
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

8.  Ultrastructural distribution of endogenous IgGs in the glomerular wall of control and diabetic rats.

Authors:  M Desjardins; M Bendayan
Journal:  Histochem J       Date:  1989-12

9.  Differential expression of basement membrane collagen chains in diabetic nephropathy.

Authors:  Y Kim; M M Kleppel; R Butkowski; S M Mauer; J Wieslander; A F Michael
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

10.  Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.

Authors:  M Brownlee; S Pongor; A Cerami
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.